Are you tired of looking tired? Introducing Restylane Eyelight, Galderma’s latest FDA-approved hyaluronic acid (HA) filler for the improvement of undereye hollows in adults over the age of 21. Eyelight leverages NASHA® cross-linking technology to produce a firmer gel ideal for the tear trough area to help fill in undereye hollows.
Restylane Eyelight will:
• replenish lost volume, lift, and smooth the tear trough area
• visibly reduce signs of fatigue by reducing shadows in the hollow under the eyes
• produce natural-looking, long-lasting results
• require no downtime
For millions of Americans, dark circles can make individuals feel older, tired and stressed. Dr. Carolyn Jacob, a board-certified dermatologist based in Chicago and a lead investigator in the clinical trial of Restylane Eyelight sees firsthand how undereye concerns are top of mind for consumers.
“Many of my patients seek treatment for hollows under the eyes, and topical products such as creams, concealers and undereye masks just aren’t able to solve the problem and provide the long-lasting results they are seeking. I’m pleased to see that Restylane Eyelight offers a safe, effective and natural-looking outcome that enables my patients to achieve their aesthetic undereye goals, with results that last up to 18 months with optimal treatment.”
Carolyn Jacob, M.D.
Restylane Eyelight lasts up to 18 months with optimal treatment.
• 94% of patients* would get Restylane Eyelight treatment again.†
• 92% of patients* thought their results looked natural after treatment.
• 87% of patients* thought they looked less tired after treatment.**,†
• Two thirds of patients* said they needed less concealer after treatment.
* Patient = Clinical trial subject
** Percent very satisfied or satisfied with question
† Patient response 3 months after treatment
The FDA approval of Restylane Eyelight adds to Galderma’s growing Restylane product portfolio. With over 65 million treatments worldwide and counting, the Restylane family of HA dermal fillers is the broadest portfolio of dermal fillers in the U.S.